Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 3,577-3,588 of 4,306
Drug study icon
CompletedNCT00431574

Antipsychotic Medication Extended Dosing Study

This summary needs review. Please check the official study record and contact the research team for details.

In Toronto
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 75 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
Behavioral study icon
CompletedNCT00541398

Antipsychotic Polypharmacy: Prevalence, Background and Consequences

This summary needs review. Please check the official study record and contact the research team for details.

In Glostrup Municipality
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 64 Years
Countries
Denmark
Sponsor
Glostrup University Hospital, Copenhagen
Condition
Schizophrenia
Other study type icon
CompletedNCT00585273

Antipsychotics and Blood Vessel Function

This summary needs review. Please check the official study record and contact the research team for details.

In Iowa City
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 50 Years
Countries
United States
Sponsor
Jess G. Fiedorowicz
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT01185743

Antipsychotics and Gene Expression in Soft Tissues

This summary needs review. Please check the official study record and contact the research team for details.

In Vienna
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 45 Years
Countries
Austria
Sponsor
Medical University of Vienna
Condition
Schizophrenia
Drug study icon
CompletedNCT00101569

Aripiprazole Oral Acceptability study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Anaheim
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00102479

Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityDrugFrom 10 Years to 17 Years
Countries
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia, Bipolarity
Drug study icon
TerminatedNCT02717130

Aripiprazole, Abilify Maintena Collaborative Clinical Protocol

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Columbia
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Florida Atlantic University
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.